Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,256 | Dovepress* | 3,830+ | 77 | 3,907 | |
| PubMed Central* | 426 | 198 | 624 | ||
| Totals | 4,256 | 275 | 4,531 | ||
| *Since 2 December 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar